Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 178 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Post Marketing Surveillance on Piqray in Korea

 		Breast Cancer Korea, Republic of

Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world

 		Breast Cancer India

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis

 		Multiple Sclerosis (MS) Phase3 United States
Germany
Argentina
Mexico
Brazil
Belgium
Guatemala
India
France
Chile
Italy
Canada
Australia
Israel
Latvia
Estonia
Austria
Croatia
View All

Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.

 		Melanoma Turkey

Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria

 		Paroxysmal Nocturnal Hemoglobinuria Phase3 United States
Germany
Italy
Spain
Malaysia
France
Korea, Republic of
Singapore
View All

Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

 		Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma Brazil

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

 		Hyperlipoproteinemia (a) Phase3 Germany

Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)

 		Systemic Lupus Erythematosus Phase3 United States
Germany
France
Colombia
Argentina
Chile
Australia
View All

A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia

 		HR+HER2- Advanced Breast Cancer Russian Federation

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

 		Primary Immune Thrombocytopenia (ITP) Phase3 United States
China
Belgium
Argentina
Australia
Austria
Bulgaria
View All